A Study of Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) and MK-8527 in Healthy Participants
Clinical trial NCT06816043 · COMPLETED
Trial details
- NCT number
- NCT06816043
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-21
- Primary completion
- 2025-06-05
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.